Skip to content

Neogen NEOG Return on equity

Return on equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
Idexx Laboratories logo
Idexx LaboratoriesIDXX
72.9%+13.6pp
Zoetis logo
ZoetisZTS
67%+15.8pp
Revvity logo
RevvityRVTY
3.2%-0.5pp
TEC
Bio-TechneTECH
6.5%-3.9pp
Agilent Technologies logo
Agilent TechnologiesA
21.3%+2.4pp

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$1.92B+12.0%
Enterprise value$2.56B+4.4%
P/S2.2×+0.3×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Calculated from Neogen’s reported figures.

Based on trailing twelve months.

The official record: Neogen’s 10-Q, filed April 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neogen's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's return on equity?
Neogen (NEOG) reported return on equity of -25.6% in Q4 2025.
How has Neogen's return on equity changed year-over-year?
Neogen's return on equity decreased by 53.0% year-over-year, from -16.7% to -25.6%.
What is the long-term trend for Neogen's return on equity?
Over 3 years (2021 to 2025), Neogen's return on equity has grown at a 75.3% compound annual growth rate (CAGR), from 7.8% to -41.9%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.